Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Diarrhea 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Irinotecan 4Octreotide 3Probiotics 2Leucovorin 2Fluorouracil 2shosaiko-to 1maltodextrin 1lanreotide 1isatuximab 1bile acid binding proteins 1Temozolomide 1Sulfasalazine 1Raloxifene Hydrochloride 1Radiation 1Oxaliplatin 1Loperamide 1Long-Term Synaptic Depression 1Levofloxacin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Diet Therapy 1Cyclophosphamide 1Colesevelam Hydrochloride 1Celecoxib 1Cefpodoxime 1Cefixime 1Calcium Aluminosilicate 1Anti-Bacterial Agents 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diarrhea × Calcium Aluminosilicate × Clear all
NCT00748215 2020-12-02

Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan

M.D. Anderson Cancer Center

Phase 2 Completed
100 enrolled 17 charts
Gastrointestinal

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡